Nesina (alogliptin)

Facts of Nesina (alogliptin)

Medicine Name: NESINA
Generic Name: alogliptin
Approval Date: Jan. 8, 2014
Company Name: Takeda Pharmaceuticals America, Inc.
Available as (Form & Strength): Tablets: 25 mg, 12.5 mg and 6.25 mg

What is indication and usage?

NESINA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings

Limitation of Use

NESINA should not be used in patients with ty pe 1 diabetes mellitus or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. .

What is NESINA?

NESINA (pronounced neh-SEE-nah) is an FDA- approved prescription medication, that along with diet and exercise, can be taken orally once daily to help improve blood sugar control in adults with type 2 diabetes. Individual results may vary.